A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD

Status:
Completed

Trial end date:
2016-05-01

Target enrollment:

Participant gender:

Efficacy of Fluticasone/Formoterol in COPD Treatment. The Effect study.

Phase 3

Mundipharma Research Limited

Formoterol Fumarate